Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724708 | SCV000231610 | uncertain significance | not provided | 2015-04-10 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000221172 | SCV000270783 | likely benign | not specified | 2015-01-14 | criteria provided, single submitter | clinical testing | p.Asp534Asp in exon 6 of RBM20: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.2% (4/2290) of A frican American chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs76048624). |
Gene |
RCV000724708 | SCV000514382 | likely benign | not provided | 2020-10-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001079157 | SCV000562769 | likely benign | Dilated cardiomyopathy 1DD | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399639 | SCV002709165 | likely benign | Cardiovascular phenotype | 2018-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000221172 | SCV001927896 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724708 | SCV001974925 | likely benign | not provided | no assertion criteria provided | clinical testing |